GLP-1 SEMA
$39.99
Semaglutide (GLP-1 Receptor Agonist)
Product Overview
Semaglutide is a highly advanced, long-acting GLP-1 (glucagon-like peptide-1) receptor agonist that mimics the native incretin hormone. Engineered with a specialized C18 fatty diacid chain, this peptide binds to serum albumin to significantly extend its half-life, allowing for sustained, once-weekly application profiles. It is a premier compound for researching the metabolic pathways involved in blood glucose regulation, profound appetite suppression, and energy homeostasis.
Technical Specifications
Molecular Formula: C187H291N45O59
Molecular Weight: 4113.58 g/mol
CAS Number: 910463-68-2
Sequence Profile: 31-amino acid modified peptide featuring a C18 fatty diacid chain attached via a mini-PEG linker
Mechanism of Action
Semaglutide exerts its effects by activating GLP-1 receptors throughout the body, providing continuous engagement rather than transient postprandial spikes:
Pancreatic Function: Enhances glucose-dependent insulin secretion while suppressing glucagon release.
Central Nervous System: Crosses the blood-brain barrier to target hypothalamic satiety centers, deeply suppressing appetite and reducing food reward signaling.
Gastrointestinal Tract: Slows gastric emptying, prolonging satiety and modulating glucose absorption rates.
Primary Research Applications
Semaglutide is a cornerstone compound for in vitro and animal model studies focusing on:
Advanced Weight Management and Adipose Tissue Reduction
Type 2 Diabetes, Glycemic Control, and Beta-Cell Protection
Cardiovascular Risk Reduction and Endothelial Function
Non-Alcoholic Fatty Liver Disease (NAFLD) and NASH Pathways
Emerging Neuroprotective and Neuro-inflammatory Research
Storage & Handling
For optimal stability and structural integrity, store unopened vials at 36°F to 46°F (2°C to 8°C). Once reconstituted or in-use, it may be stored at controlled room temperature for up to 56 days. Protect strictly from light.
⚠️ Important Disclaimer for Carbon Nova Labs Customers: All information provided is for educational and reference purposes only. Semaglutide is sold strictly for laboratory research use only. This compound is not approved by the FDA for human consumption, therapeutic use, or clinical application. Ensure compliance with all institutional safety protocols and consult qualified professionals before conducting research.